UA109112C2 - Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями - Google Patents

Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями

Info

Publication number
UA109112C2
UA109112C2 UAA201114512A UAA201114512A UA109112C2 UA 109112 C2 UA109112 C2 UA 109112C2 UA A201114512 A UAA201114512 A UA A201114512A UA A201114512 A UAA201114512 A UA A201114512A UA 109112 C2 UA109112 C2 UA 109112C2
Authority
UA
Ukraine
Prior art keywords
short
high temperature
time high
inflammatory disorders
therapy
Prior art date
Application number
UAA201114512A
Other languages
English (en)
Russian (ru)
Inventor
Гунолі Пріул
Аннік Мерсеньє
Original Assignee
Нестек С.А.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40810221&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UA109112(C2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Нестек С.А. filed Critical Нестек С.А.
Publication of UA109112C2 publication Critical patent/UA109112C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/005—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor after treatment of microbial biomass not covered by C12N1/02 - C12N1/08
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pulmonology (AREA)
  • Sustainable Development (AREA)
  • Dermatology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Ophthalmology & Optometry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Винахід належить до підданих короткотривалій високотемпературній обробці мікроорганізмів для лікування або профілактики запальних захворювань, наприклад пробіотиків і/або культур молочних заквасок.
UAA201114512A 2009-05-11 2010-05-07 Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями UA109112C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09159925A EP2251020A1 (en) 2009-05-11 2009-05-11 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
PCT/EP2010/056284 WO2010130659A1 (en) 2009-05-11 2010-05-07 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles

Publications (1)

Publication Number Publication Date
UA109112C2 true UA109112C2 (uk) 2015-07-27

Family

ID=40810221

Family Applications (2)

Application Number Title Priority Date Filing Date
UAA201114512A UA109112C2 (uk) 2009-05-11 2010-05-07 Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями
UAA201114511A UA107573C2 (xx) 2009-05-11 2010-07-05 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) І ІМУННІ РОЗЛАДИ

Family Applications After (1)

Application Number Title Priority Date Filing Date
UAA201114511A UA107573C2 (xx) 2009-05-11 2010-07-05 LACTOBACILLUS JOHNSONII La1 NCC533 (CNCM I-1225) І ІМУННІ РОЗЛАДИ

Country Status (15)

Country Link
US (1) US20120141443A1 (uk)
EP (2) EP2251020A1 (uk)
JP (1) JP2012526748A (uk)
CN (1) CN102740866B (uk)
AR (1) AR076675A1 (uk)
AU (1) AU2010247466B2 (uk)
BR (1) BRPI1011156A8 (uk)
CA (1) CA2761667A1 (uk)
CL (1) CL2011002849A1 (uk)
MX (1) MX337762B (uk)
RU (1) RU2542413C2 (uk)
TW (1) TW201100537A (uk)
UA (2) UA109112C2 (uk)
WO (1) WO2010130659A1 (uk)
ZA (1) ZA201109088B (uk)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102802648A (zh) 2009-05-11 2012-11-28 雀巢产品技术援助有限公司 约氏乳杆菌La1 NCC533(CNCM I-1225)和免疫病症
WO2011149335A1 (en) * 2010-05-25 2011-12-01 N.V. Nutricia Immune imprinting nutritional composition
EA024923B1 (ru) * 2010-07-15 2016-11-30 Компани Жервэ Данон Применение марганца для селективной стимуляции роста lactobacillus casei в смешанных культурах
EP2449890A1 (en) * 2010-11-05 2012-05-09 Nestec S.A. Powdered cereal compositions comprising non-replicating probiotic microorganisms
EP2455093A1 (en) * 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic bacteria and prevention or treatment of infections in children
EP2455094A1 (en) 2010-11-11 2012-05-23 Nestec S.A. Non-replicating probiotic micro-organisms protect children against gastrointestinal infections
GB201112091D0 (en) 2011-07-14 2011-08-31 Gt Biolog Ltd Bacterial strains isolated from pigs
GB201117313D0 (en) 2011-10-07 2011-11-16 Gt Biolog Ltd Bacterium for use in medicine
CN104220054A (zh) * 2012-03-30 2014-12-17 雀巢产品技术援助有限公司 4-氧代-2-戊烯酸和消化道的健康
US9238015B2 (en) * 2012-03-30 2016-01-19 Nestec S.A. 4-oxo-2-pentenoic acid and cardiovascular health
RU2015125548A (ru) 2012-11-29 2017-01-11 Нестек С.А. Синбиотическая композиция и ее использование
US9820504B2 (en) 2013-03-08 2017-11-21 Axiom Foods, Inc. Rice protein supplement and methods of use thereof
CA2901469A1 (en) 2013-03-08 2014-09-12 Axiom Foods, Inc. Rice protein supplements
GB201306536D0 (en) 2013-04-10 2013-05-22 Gt Biolog Ltd Polypeptide and immune modulation
CN105658226B (zh) * 2013-08-16 2019-05-14 港大科桥有限公司 使用益生菌治疗癌症的方法和组合物
EP3091861A1 (en) 2013-11-25 2016-11-16 Nestec S.A. Heat-treated formulation of bifidobacterium lactis ncc 2818 reduces allergic manifestations
KR20220151045A (ko) 2014-12-23 2022-11-11 4디 파마 리서치 리미티드 면역 조정
SG10202105996WA (en) 2014-12-23 2021-07-29 4D Pharma Res Ltd Pirin polypeptide and immune modulation
MA41010B1 (fr) 2015-06-15 2020-01-31 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
PL3206700T3 (pl) 2015-06-15 2019-11-29 4D Pharma Res Ltd Kompozycje zawierające szczepy bakteryjne
MD3240554T2 (ro) 2015-06-15 2020-01-31 4D Pharma Res Ltd Blautia stercosis și wexlerae pentru utilizare în tratarea bolilor inflamatorii și autoimune
RS59308B1 (sr) 2015-06-15 2019-10-31 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
MA41060B1 (fr) 2015-06-15 2019-11-29 4D Pharma Res Ltd Compositions comprenant des souches bactériennes
BR112018007560A2 (pt) * 2015-10-15 2018-10-23 Natura Cosméticos S.A. composição cosmética tendo bactérias probióticas
ITUB20155700A1 (it) * 2015-11-18 2017-05-18 Probiotical Spa Composizioni con azione sinergica tra un complesso gelificante muco-aderente contro il passaggio degli antigeni, e batteri immunomodulanti anti-IL17 per uso nel trattamento delle malattie autoimmuni e neurodegenerative IL17 dipendenti.
GB201520497D0 (en) 2015-11-20 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
ME03003B (me) 2015-11-20 2018-10-20 4D Pharma Res Ltd Kompozicije koje sadrže bakterijske sojeve
GB201520631D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
GB201520638D0 (en) 2015-11-23 2016-01-06 4D Pharma Res Ltd Compositions comprising bacterial strains
WO2017097984A1 (en) * 2015-12-11 2017-06-15 Alimentary Health Limited Lactobacillus casei for treating obesity and associated metabolic disorders
GB201612191D0 (en) 2016-07-13 2016-08-24 4D Pharma Plc Compositions comprising bacterial strains
RS58869B1 (sr) 2016-03-04 2019-08-30 4D Pharma Plc Kompozicije koje sadrže blautia bakterijske sojeve za lečenje visceralne hipersenzitivnosti
TW201821093A (zh) 2016-07-13 2018-06-16 英商４Ｄ製藥有限公司 包含細菌菌株之組合物
EP3272396A1 (en) * 2016-07-18 2018-01-24 Bionou Research, S.L. Use of probiotics in the treatment and/or prevention of atopic dermatitis
GB201621123D0 (en) 2016-12-12 2017-01-25 4D Pharma Plc Compositions comprising bacterial strains
EP3634155A4 (en) 2017-05-12 2021-02-17 Axiom Foods Inc. RICE PRODUCTS AND SYSTEMS AND PROCESSES FOR THEIR PRODUCTION
TWI787272B (zh) 2017-05-22 2022-12-21 英商4D製藥研究有限公司 包含細菌菌株之組合物
JP6978514B2 (ja) 2017-05-24 2021-12-08 フォーディー ファーマ リサーチ リミテッド4D Pharma Research Limited 細菌株を含む組成物
KR20200015575A (ko) 2017-06-14 2020-02-12 4디 파마 리서치 리미티드 세균 균주를 포함하는 조성물
JP6884889B2 (ja) 2017-06-14 2021-06-09 フォーディー ファーマ リサーチ リミテッド４Ｄ Ｐｈａｒｍａ Ｒｅｓｅａｒｃｈ Ｌｉｍｉｔｅｄ 細菌株を含む組成物
CN109198351A (zh) * 2017-07-09 2019-01-15 许昌神飞航天生物科技有限公司 一种排毒养胃的航天员专用益生菌固体饮料
WO2019019961A1 (zh) * 2017-07-26 2019-01-31 海思科医药集团股份有限公司 防治消化道和/或皮肤反应的菌群及其应用
MX2020004934A (es) * 2017-11-15 2020-12-03 Evelo Biosciences Inc Composiciones y metodos para el tratamiento de los trastornos inmunitarios utilizando cepas de bacterias inmunomoduladoras de lactococcus.
WO2019129807A1 (en) * 2017-12-29 2019-07-04 Societe Des Produits Nestle S.A. Serpin production
TWI731209B (zh) * 2018-01-09 2021-06-21 柯順議 益生菌組合物及其用途
BE1025428B1 (nl) * 2018-01-23 2019-02-14 Omega Pharma Innovation & Development Nv Voedingssupplement en gebruiken daarvan
BR112021005316A2 (pt) * 2018-10-02 2021-06-15 Société des Produits Nestlé S.A. combinação de probióticos para o tratamento de distúrbios gastrointestinais relacionados à inflamação
AU2019410036A1 (en) * 2018-12-21 2021-06-03 Société des Produits Nestlé S.A. Probiotic combination for treatment of allergic disorders
CN110893194B (zh) * 2019-11-20 2023-03-14 内蒙古伊利实业集团股份有限公司 乳双歧杆菌bl-99在抑制肠道炎症方面的新应用
CN111560330B (zh) * 2020-05-12 2022-04-26 天津科技大学 一种具有免疫调节、抗炎和抗宫颈癌作用的干酪乳杆菌及应用
CN113215029B (zh) * 2021-04-12 2022-06-24 天津中医药大学 一种约氏乳杆菌及其应用
CN114129600A (zh) * 2021-11-30 2022-03-04 河北一然生物科技股份有限公司 一种复合益生菌制剂在抗炎产品中的新应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000095697A (ja) * 1998-09-18 2000-04-04 Advance Co Ltd 抗アレルギー剤
WO2000049881A1 (en) * 1999-02-25 2000-08-31 Societe Des Produits Nestle S.A. Use of l-alanine as a sweetener
EP1110555A1 (fr) * 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
AU784898B2 (en) * 2000-01-18 2006-07-20 Societe Des Produits Nestle S.A. Pet food composition for treating helicobacter species in pets
EP1384483A1 (en) * 2002-07-23 2004-01-28 Nestec S.A. Probiotics for treatment of irritable bowel disease (IBS) through improvement of gut neuromuscular function
WO2004069156A2 (en) * 2003-01-30 2004-08-19 The Regents Of The University Of California Inactivated probiotic bacteria and methods of use thereof
EP1675480B1 (en) * 2003-10-16 2018-06-13 Nestec S.A. Nutritional composition against side effects of chemotherapy of radiotherapy
WO2005091933A2 (en) * 2004-03-04 2005-10-06 E-L Management Corporation Skin treatment method with lactobacillus extract
BRPI0516437A (pt) * 2004-10-04 2008-09-02 Oreal E Nestec S A L utilização de uma quantidade eficaz de pelo menos um microorganismo, processo de tratamento cosmético, composição cosmética e/ou dermatológica e composição para absorção oral
JP4409488B2 (ja) * 2004-11-30 2010-02-03 株式会社京都栄養化学研究所 クロレラ発酵食品の製造方法
AU2006221148A1 (en) * 2005-03-08 2006-09-14 Fonterra Co-Operative Group Limited High pressure processing of metal ion lactoferrin
KR100578395B1 (ko) * 2005-11-11 2006-05-10 주식회사 바이오리더스 면역기능이 강화된 사균화 유산균 제제 및 그 제조방법
WO2007093619A1 (en) * 2006-02-15 2007-08-23 Nestec S.A. Use of bifidobacterium longum for the prevention and treatment of inflammation
JP5031249B2 (ja) * 2006-03-22 2012-09-19 学校法人北里研究所 炎症抑制作用のある菌体含有組成物
JP2007320891A (ja) * 2006-05-31 2007-12-13 Im Press Kk 経口用皮膚美容促進組成物
FR2912916B1 (fr) * 2007-02-26 2009-05-22 Oreal Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire
WO2008106372A1 (en) * 2007-02-28 2008-09-04 Mead Johnson Nutrition Company Method for treating or preventing systemic inflammation
EP1992351B1 (en) * 2007-05-18 2016-05-11 Nestec S.A. Lactobacillus johnsonii for prevention of postsurgical infection
WO2008153377A1 (en) * 2007-06-15 2008-12-18 N.V. Nutricia Nutrition with non-viable bifidobacterium and non-digestible oligosaccharide
FI20075539L (fi) * 2007-07-12 2009-01-13 Valio Oy Maitohappobakteerit, joilla on proinflammatorisia ominaisuuksia
EP2022502A1 (en) * 2007-08-10 2009-02-11 Nestec S.A. Lactobacillus rhamnosus and weight control
FR2922450B1 (fr) * 2007-10-19 2014-06-13 Lallemand Sas Utilisation de bacteries lactique pour la prevention et/ou le traitement de pathologies cutanees
US9113641B2 (en) * 2007-12-06 2015-08-25 Arla Foods Amba Probiotic bacteria and regulation of fat storage
MX2011006701A (es) * 2008-12-19 2011-07-28 Nestec Sa Prevencion y tratamiento de diarrea por rotavirus.

Also Published As

Publication number Publication date
EP2251020A1 (en) 2010-11-17
EP2429544A1 (en) 2012-03-21
CN102740866B (zh) 2016-05-18
UA107573C2 (xx) 2015-01-26
BRPI1011156A8 (pt) 2016-10-04
BRPI1011156A2 (pt) 2016-03-15
CA2761667A1 (en) 2010-11-18
US20120141443A1 (en) 2012-06-07
MX2011012065A (es) 2012-01-20
CL2011002849A1 (es) 2012-06-01
RU2011150201A (ru) 2013-06-20
CN102740866A (zh) 2012-10-17
TW201100537A (en) 2011-01-01
JP2012526748A (ja) 2012-11-01
AR076675A1 (es) 2011-06-29
AU2010247466B2 (en) 2015-09-03
AU2010247466A1 (en) 2011-12-08
MX337762B (es) 2016-03-17
WO2010130659A1 (en) 2010-11-18
ZA201109088B (en) 2016-08-31
EP2429544B1 (en) 2016-04-20
RU2542413C2 (ru) 2015-02-20

Similar Documents

Publication Publication Date Title
UA109112C2 (uk) Короткотривала високотемпературна обробка, що дозволяє одержати мікробні препарати із протизапальними профілями
MY166552A (en) Infant cereal comprising non-replicating probiotic microorganisms
IN2012DN01638A (uk)
EP2440210A4 (en) METHOD FOR THE TREATMENT OF STOMACH DARM DISEASES
PH12019502725A1 (en) Use of lactic acid bacteria to treat or prevent at least one of postnatal depression and postnatal anxiety
MX2013004372A (es) Productos de confiteria que contienen microorganismos probioticos.
CL2011002852A1 (es) Uso de bacterias del acido lactico probioticas por un tratamiento con calor para la preparacion de composiciones para prevenir o tratar inmunodeficiencias causadas por infecciones bacterianas, virales, fungicas y/o parasitarias.
MX347262B (es) Preparaciones de alimento para mascotas que contienen microorganismos probióticos.
MX2012006628A (es) Microorganismos probioticos como agentes activos para mejorar el brillo de la piel.
ZA201207377B (en) Composition comprising probiotic bacteria for use in the treatment of immune disorders
NZ598694A (en) Iminothiadiazine dioxide compounds as bace inhibitors, compositions, and their use
IL202386A0 (en) Mammalian milk microorganisms, compositions containing them and their use for the treatment of mastitis
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MX2019008122A (es) Derivados de aminas heterociclicas que inhiben la transduccion de se?al mediada por cinasa asociada con el receptor de interleucina-1.
MX357528B (es) Metodos para el tratamiento de trastornos metabolicos usando intercambiadores epimetabolicos, moleculas intracelulares multidimensionales o influencias ambientales.
SG10201407403UA (en) Treatments For Gastrointestinal Disorders
MX356755B (es) Compuestos de tipo fumagilol y metodos para su elaboración y uso.
MY150931A (en) Substituted oxazolidinones and their use
UA118339C2 (uk) Бактеріальний штам lactobacillus gasseri для лікування порушення моторики кишечнику (варіанти)
MX2014001393A (es) 3-(bifenil-3-il)-4-hidroxi-8-metoxi-1-azaespiro[4.5]dec-3-en-2-on as sustituidas.
MX2013002121A (es) Quinolina-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX342119B (es) 2-oxi-quinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
MX2015005733A (es) Compuestos triciclicos para usarse en el tratamiento y/o control de obesidad.
MX2010009753A (es) Composiciones que contienen apoaecuorina y metodos de uso de las mismas.
EA201590884A1 (ru) Способы лечения заболеваний печени